These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19592301)

  • 1. Follow-up PET studies in case of idiopathic REM sleep behavior disorder.
    Miyamoto T; Orimo S; Miyamoto M; Hirata K; Adachi T; Hattori R; Suzuki M; Ishii K
    Sleep Med; 2010 Jan; 11(1):100-1. PubMed ID: 19592301
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
    Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid loss of striatal VMAT2 binding associated with onset of Lewy body dementia.
    Albin R; Koeppe R
    Mov Disord; 2006 Feb; 21(2):287-8. PubMed ID: 16258980
    [No Abstract]   [Full Text] [Related]  

  • 4. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
    Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
    Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
    Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Zhou L; Li G; Zhang Y; Zhang M; Chen Z; Zhang L; Wang X; Zhang M; Ye G; Li Y; Chen S; Li B; Wei H; Liu J
    Brain; 2021 Jun; 144(5):1488-1497. PubMed ID: 33880500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders.
    Marshall V; Grosset DG
    Mov Disord; 2003 Oct; 18 Suppl 7():S22-7. PubMed ID: 14531042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
    Shinotoh H; Hirayama K; Tateno Y
    Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
    [No Abstract]   [Full Text] [Related]  

  • 9. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.
    Kim YK; Yoon IY; Kim JM; Jeong SH; Kim KW; Shin YK; Kim BS; Kim SE
    Eur J Neurol; 2010 Mar; 17(3):487-92. PubMed ID: 19968708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac denervation precedes nigrostriatal damage in idiopathic rapid eye movement sleep behavior disorder.
    Salsone M; Labate A; Quattrone A
    Mov Disord; 2012 Jul; 27(8):1068-9. PubMed ID: 22605537
    [No Abstract]   [Full Text] [Related]  

  • 11. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL; Watts RL; Stoessl AJ; Davis M; Reske S; Nahmias C; Lang AE; Rascol O; Ribeiro MJ; Remy P; Poewe WH; Hauser RA; Brooks DJ;
    Ann Neurol; 2003 Jul; 54(1):93-101. PubMed ID: 12838524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract]   [Full Text] [Related]  

  • 14. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
    Nurmi E; Ruottinen HM; Kaasinen V; Bergman J; Haaparanta M; Solin O; Rinne JO
    Ann Neurol; 2000 Jun; 47(6):804-8. PubMed ID: 10852547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder.
    Mazza S; Soucy JP; Gravel P; Michaud M; Postuma R; Massicotte-Marquez J; Decary A; Montplaisir J
    Neurology; 2006 Nov; 67(9):1618-22. PubMed ID: 17101893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
    Mendez I; Dagher A; Hong M; Gaudet P; Weerasinghe S; McAlister V; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
    J Neurosurg; 2002 Mar; 96(3):589-96. PubMed ID: 11883846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the brain network in idiopathic rapid eye movement sleep behavior disorder: structural connectivity analysis.
    Park KM; Lee HJ; Lee BI; Kim SE
    Sleep Breath; 2019 Jun; 23(2):587-593. PubMed ID: 30315394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.
    Menza MA; Mark MH; Burn DJ; Brooks DJ
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):176-9. PubMed ID: 7626960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.